| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 12 |
| 1 | VENETOCLAX | 12 |
| 2 | IBRUTINIB | 11 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 6 |
| 4 | BENDAMUSTINE HCL | 4 |
| 5 | LENALIDOMIDE | 3 |
| 6 | OBINUTUZUMAB | 3 |
| 7 | CYCLOPHOSPHAMIDE | 2 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENDAMUSTINE HYDROCHLORIDE | 6 | 0.0007 |
| 1 | BENDAMUSTINE HCL | 4 | 0.0003 |
| 2 | CHLORAMBUCIL | 1 | 0.0003 |
| 3 | VENETOCLAX | 12 | 0.0002 |
| 4 | OBINUTUZUMAB | 3 | 0.0002 |
| 5 | IDELALISIB | 1 | 0.0001 |
| 6 | IBRUTINIB | 11 | 0.0001 |
| 7 | AMPICILLIN INJECTION | 1 | 0.0001 |
| 8 | AMPICILLIN | 1 | 0.0001 |
| 9 | DEXAMETHASONE SODIUM PHOSPHATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 12 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 13 | 0.0000 |
| 3 | Kinase Inhibitor [EPC] | 12 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 6 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |